SCHEMBL13554338

SCHEMBL13554338

CCC1C2CC3CC(C2)CC1(OC(=O)CCOC(=O)C(C)(C)CC)C3

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 11/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15889448 0.88 EPHX2 (0.30) EPHX2
SCHEMBL11926446 0.88 EPHX2 (0.31) EPHX2
SCHEMBL14929439 0.87 EPHX2 (0.34) EPHX2
SCHEMBL13554336 0.87 EPHX2 (0.34) EPHX2
SCHEMBL11926448 0.86 EPHX2 (0.33) EPHX2
SCHEMBL683013 0.85 ALDH1A1 (0.31)
SCHEMBL12555072 0.81 EPHX2 (0.37) EPHX2
SCHEMBL14929420 0.78 EPHX2 (0.34) EPHX2
SCHEMBL11926447 0.75 EPHX2 (0.31) EPHX2
SCHEMBL13779611 0.75 EPHX2 (0.48) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9005874-B2 Compound, polymeric compound, acid generator, resist composition, and method of forming resist pattern TOKYO OHKA KOGYO CO., LTD. (JP) 2015-04-14 US disclosed
US-20120270155-A1 COMPOUND, POLYMERIC COMPOUND, ACID GENERATOR, RESIST COMPOSITION, AND METHOD OF FORMING RESIST PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2012-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270155-A1 COMPOUND, POLYMERIC COMPOUND, ACID GENERATOR, RESIST COMPOSITION, AND METHOD OF FORMING RESIST PATTERN ASIC1, FGFR1, FGF1 EPHX2 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.